| Knowing which vaccines are being supplied in the U.S. — and in what numbers — is just as important as knowing how many shots are going into arms. But because of a bifurcated U.S. distribution system, we're getting less and less detailed data from the federal government each week on how many doses each vaccine manufacturer is actually delivering. It's a situation that makes it harder to know if drugmakers are meeting their commitments and how the federal government is allocating shots. To understand U.S. vaccine distribution, you first need to know that it's split into two parts. The first is state-based. The Department of Health and Human Services each week announces vaccine allocations. States order doses, and they're shipped out. This has been the biggest part of the system, accounting for 17.6 million of 28 million doses made available this week.  We have great data for this program: Each week, the Centers for Disease Control and Prevention publishes a file showing how many doses have been allocated to each state and which drug company made them. The second part is what we call the federal-direct program. These are doses that the U.S. sends directly to pharmacies, federally qualified health centers, kidney-care centers and other locations. These doses make up an increasingly large part of weekly shipments —10.4 million out of 28 million shots made available this week. There is far less public data here. The White House announces a grand total once a week but doesn't provide breakdowns of which vaccines are going where, or in what quantities. As a result, the Bloomberg Vaccine Tracker's supply chart contains an increasingly large category of "unknown" doses — shots delivered to the federal government but without public information on who made them.  Pharmacies like CVS receive vaccine doses directly from the U.S. government. Photographer: Gabriela Bhaskar/Bloomberg We've repeatedly asked the Department of Health and Human Services for this information, and have been told for several weeks that they're working on it. We still don't have it. Getting a complete picture is important for several reasons. It tells us, in near-real time, if vaccine makers like Pfizer, Moderna and Johnson & Johnson are meeting their production commitments. Detailed data on the federal program would also reveal if the U.S. is moving away from its strategy of allocating vaccines largely on a per capita basis to distributing them by demand or need, something that governors and mayors have called for as surpluses build in some places. This administration, to its credit, has been increasingly responsive to our vaccine data questions. The CDC has produced more information about how vaccines are used, and has been more transparent about explaining that information. But data drives accountability. And without knowing how many vaccine doses are being handed over to the U.S. and from which companies, it's harder to know if the promises made by drugmakers are being met, harder to know how those shots are being allocated, and harder to know where the U.S. vaccine campaign is headed. —Drew Armstrong | 
⊗⋗⋮〖~DownLoad!〗 2021 Initiation Full Movie Online released 2021. story: Whiton University unravels the night a star-athlete is murdered, k...
Post a Comment